Sign in
Taking peopleNo phase

Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients

Key facts

Who runs it
Region Skane
Where
Finland, Sweden, and United Kingdom22 sites in 3 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
1,850 people, planned
Started
27 Nov 2023
Expected to end
1 Jul 2028
Type of study
Interventional, 2 groups
Treatments tested
  • Protocolised reduction of non-resuscitation fluids
  • Usual care
Record updated
6 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Adult (≥ 18 years of age)
  • Septic shock according to the Sepsis 3 criteria at any time within 12 hours after ICU admission (suspected or confirmed infection, plasma lactate above 2 mmol/L, and infusion of vasopressor/inotrope to maintain mean arterial pressure of 65mmHg or above after receiving adequate fluid resuscitation [> 1L within 12 h of screening]) and need for vasopressors at the time of screening

Who cannot take part

  • Previous inclusion in the trial
  • Confirmed or suspected pregnancy
  • Screened more than 12 hours after ICU admission

This trial has no sites in United States.

It has sites in 3 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this trial is to assess the beneficial and harmful effects of a restrictive strategy for administration of non-resuscitation fluids in adult patients with septic shock.

The 2 groups in the trial

  • Protocolised reduction of non-resuscitation fluidsTreatment being tested

    Participants receive non-resuscitation fluids according to a pre-defined protocol starting within two hours of randomization. The intervention is continued for the duration of the ICU admission up to a maximum of 90 days.

  • Usual CareOther group

    Participants receive non-resuscitation fluids according to local routines.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
6 October 2026